000 | 01978 a2200565 4500 | ||
---|---|---|---|
005 | 20250514080307.0 | ||
264 | 0 | _c20031002 | |
008 | 200310s 0 0 eng d | ||
022 | _a0014-4886 | ||
024 | 7 |
_a10.1016/s0014-4886(03)00080-3 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHarvey, B K | |
245 | 0 | 0 |
_aHSV amplicon delivery of glial cell line-derived neurotrophic factor is neuroprotective against ischemic injury. _h[electronic resource] |
260 |
_bExperimental neurology _cSep 2003 |
||
300 |
_a47-55 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAstrocytes _xdrug effects |
650 | 0 | 4 |
_aBrain _xblood supply |
650 | 0 | 4 | _aCaspase 3 |
650 | 0 | 4 |
_aCaspases _xmetabolism |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aGenetic Therapy _xmethods |
650 | 0 | 4 |
_aGenetic Vectors _xadministration & dosage |
650 | 0 | 4 | _aGlial Cell Line-Derived Neurotrophic Factor |
650 | 0 | 4 |
_aGlial Fibrillary Acidic Protein _xmetabolism |
650 | 0 | 4 |
_aHydrogen Peroxide _xtoxicity |
650 | 0 | 4 | _aImmunohistochemistry |
650 | 0 | 4 |
_aIschemic Attack, Transient _xpathology |
650 | 0 | 4 |
_aMotor Activity _xdrug effects |
650 | 0 | 4 |
_aNerve Growth Factors _xadministration & dosage |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xadministration & dosage |
650 | 0 | 4 |
_aOxidants _xtoxicity |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aRecovery of Function |
650 | 0 | 4 |
_aSimplexvirus _xgenetics |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aChang, C F | |
700 | 1 | _aChiang, Y H | |
700 | 1 | _aBowers, W J | |
700 | 1 | _aMorales, M | |
700 | 1 | _aHoffer, B J | |
700 | 1 | _aWang, Y | |
700 | 1 | _aFederoff, H J | |
773 | 0 |
_tExperimental neurology _gvol. 183 _gno. 1 _gp. 47-55 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0014-4886(03)00080-3 _zAvailable from publisher's website |
999 |
_c12726584 _d12726584 |